Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, August 2, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Carter Gould Maintained (TVTX) at Buy with Increased Target to $14 on, Aug 2nd, 2024
Published on 2024-10-28 13:06:10 - WOPRAI, Carter Gould
Carter Gould of Barclays, Maintained "Travere Therapeutics, Inc." (TVTX) at Buy with Increased Target from $12 to $14 on, Aug 2nd, 2024.
Carter has made no other calls on TVTX in the last 4 months.
There are 2 other peers that have a rating on TVTX. Out of the 2 peers that are also analyzing TVTX, 0 agree with Carter's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Carter
- Ed Arce of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $19 on, Tuesday, May 7th, 2024
- Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $18 on, Tuesday, May 7th, 2024
